跳至主要内容
临床试验/ACTRN12611000046909
ACTRN12611000046909进行中(未招募)未知

Microencapsulation for Enhanced Bioavailability of Fish Oil in Healthy Adult Volunteers - Long Term Ingestion Study

CSIRO Preventative Health Flagship0 个研究点目标入组 50 人开始时间: 2011年1月13日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • (1) Male and Females aged between 18-70 years
  • (2) Normal dietary habits (no medically prescribed diet, no slimming diet, and no vegan or macrobiotic diet).
  • (3) Body Mass Index >18 kg/m^2 < 35kg/m^2 (calculation: Body Mass Index = weight in kg / height^2 in m^2).
  • (4) Apparently healthy: no reported current or previous metabolic diseases, gastrointestinal disorders, renal or cardiovascular disease.
  • (5) Person having given their specific consent in writing.

排除标准

  • (1) Regular use of supplements containing omega-3 essential fatty acids must have ceased 2 months prior to the start of the study.
  • (2) Current relevant medical treatment (subject to judgement of the investigator).
  • (3) High alcohol consumption (>21 standard drinks/week)
  • (4) Reported participation in another biomedical trial 3 months before the start of the study or during the study.
  • (5) Food allergies or intolerances (dairy, lactose, peanuts, shellfish, etc…).
  • (6) Recent history (within 12 months) of substance abuse including alcohol abuse.

研究者

发起方
CSIRO Preventative Health Flagship

相似试验

Microencapsulation for Enhanced Bioavailability of... | 临床试验